Genesee Biomedical

Genesee BioMedical is a commercial-stage, revenue-generating medical device company focused on the cardiac surgery market. It employs a surgeon-centric co-development model to create a portfolio of specialized instruments, including its flagship TransForm™ McCarthy Mitral Annuloplasty ring and a range of retractors for adult and pediatric cases. With over 30 years of operational history (including legacy from its founders), the company targets niche segments within the large and stable cardiac surgery device market. Leadership consists of seasoned medical device executives with experience from Stryker, Medtronic, and other major firms.

Surgeon-centric co-development model for designing and manufacturing mechanical surgical devices for cardiac procedures, with expertise in material science and engineering for annuloplasty rings, retractors, and specialized surgical toolkits.

The cardiac surgery device market is dominated by large players like Medtronic, Edwards Lifesciences, and Abbott. Genesee competes by focusing on niche instrument categories, employing a direct surgeon collaboration model, and offering specialized products for pediatric surgery and reusable toolkits that may provide cost advantages over disposable options.